PMC:7205724 / 497-591
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
11 | 2-10 | Disease | denotes | COVID-19 | MESH:C000657245 |
17 | 36-39 | Gene | denotes | IL6 | Gene:3569 |
19 | 63-71 | Species | denotes | patients | Tax:9606 |
20 | 15-26 | Chemical | denotes | Tocilizumab | MESH:C502936 |
21 | 77-85 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T4 | 2-10 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 77-85 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T4 | 2-10 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T5 | 77-85 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
11 | 2-10 | Disease | denotes | COVID-19 | MESH:C000657245 |
20 | 15-26 | Chemical | denotes | Tocilizumab | MESH:C502936 |
17 | 36-39 | Gene | denotes | IL6 | Gene:3569 |
19 | 63-71 | Species | denotes | patients | Tax:9606 |
21 | 77-85 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T45 | 36-39 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T74 | 2-10 | NN | denotes | COVID-19 |
T75 | 12-13 | IN | denotes | • |
T76 | 15-26 | NNP | denotes | Tocilizumab |
T77 | 26-27 | -COMMA- | denotes | , |
T78 | 28-30 | DT | denotes | an |
T79 | 31-39 | NN | denotes | anti-IL6 |
T80 | 39-40 | -COMMA- | denotes | , |
T81 | 41-44 | MD | denotes | can |
T82 | 45-51 | VB | denotes | confer |
T83 | 52-59 | NN | denotes | benefit |
T84 | 60-62 | IN | denotes | in |
T85 | 63-71 | NNS | denotes | patients |
T86 | 72-76 | IN | denotes | with |
T87 | 77-85 | NN | denotes | COVID-19 |
T88 | 86-89 | CC | denotes | and |
T89 | 90-94 | JJ | denotes | high |
R69 | T82 | T75 | arg1Of | confer,• |
R70 | T76 | T77 | arg1Of | Tocilizumab,"," |
R71 | T79 | T77 | arg2Of | anti-IL6,"," |
R72 | T79 | T78 | arg1Of | anti-IL6,an |
R73 | T82 | T80 | arg1Of | confer,"," |
R74 | T76 | T81 | arg1Of | Tocilizumab,can |
R75 | T82 | T81 | arg2Of | confer,can |
R76 | T76 | T82 | arg1Of | Tocilizumab,confer |
R77 | T83 | T82 | arg2Of | benefit,confer |
R78 | T82 | T84 | arg1Of | confer,in |
R79 | T85 | T84 | arg2Of | patients,in |
R80 | T85 | T86 | arg1Of | patients,with |
R81 | T88 | T86 | arg2Of | and,with |
R82 | T87 | T88 | arg1Of | COVID-19,and |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T4 | 2-10 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 77-85 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |